Intelligence Platform
Patents
Browse 635 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9873685
Neprilysin inhibitors
granted patentUS 9873692
Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
granted patentUS 9873696
Neprilysin inhibitors
granted patentUS 9872855
(2R,4R)-5-(5β²-Chloro-2β²-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amin
granted patentUS 9868698
(2S,4R)-5-(5β²-chloro-2β²-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methy
granted patentUS 9845332
Neprilysin inhibitors
granted patentUS 9839639
Neprilysin inhibitors
granted patentUS 9840460
Neprilysin inhibitors
granted patentUS 9828367
Neprilysin inhibitors
granted patentUS 9783507
Neprilysin inhibitors
granted patentUS 9771337
Neprilysin inhibitors
granted patentUS 9771350
Diamide compounds having muscarinic receptor antagonist and Ξ²2 adrenergic receptor agonist
granted patentUS 9765028
Crystalline freebase forms of a biphenyl compound
granted patentUS 9725448
Neprilysin inhibitors
granted patentUS 9725470
Substituted naphthyridines as JAK kinase inhibitors
granted patentUS 9724359
Neprilysin inhibitors
granted patentUS 9688692
Neprilysin inhibitors
granted patentUS 9688616
Neprilysin inhibitors
granted patentUS 9682957
Diamide compounds having muscarinic receptor antagonist and Ξ²2 adrenergic receptor agonis
granted patentUS 9682052
Neprilysin inhibitors
granted patentUS 9683002
Neprilysin inhibitors
granted patentUS 9675599
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
granted patentUS 9669027
Hepatitis C virus inhibitors
granted patentUS 9670140
Neprilysin inhibitors
granted